BiotechTube
Home/EpiPharm/Prof. R. Haynes
PR

Prof. R. Haynes

Advisor, Medicinal Chemistry

EpiPharm

Therapeutic Areas

DermatologyAesthetic Medicine

EpiPharm Pipeline

DrugIndicationPhase
Artemisinin-based Topical Formulation (Artemether)Seborrhoeic KeratosisPhase 2/3
Artemisinin-based Topical FormulationMelanocytic LesionsClinical-Stage
Proprietary Multi-Active Artemisia CompositionPrevention & Treatment of Dysplastic Epidermal Cell GrowthPreclinical/Clinical-Stage

Leadership Team at EpiPharm

DR
Dr. Rosemarie Sift Carter
Chief Executive Officer (CEO)
DR
Dr. Robert Carter
Head of Development and Regulatory
PA
Prof. A. Dayan
Advisor, Preclinical Safety
DM
Dr. med. A Härtel
Medical Consultant
DA
Dr. A. Watkinson
Advisor, Formulation Development
View full EpiPharm profile